Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
Abivax
Abivax
Activities:
Research & Development
Pharmaceutical
X
LinkedIn
Trending Articles
OINDPs: Nosey about recent developments?
OINDPs are a user friendly and efficacious alternative to injectables in several disease areas
Transforming healthcare with patient centricity
In this opinion article, John Kytariolos, Head of Clinical and Scientific Affairs at Adragos Pharma, discusses patient-centric dosage forms, their properties and the impact...
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
Compact process thermostat for efficient temperature control in the laboratory
The temperature control system is designed for the accurate temperature control of small research reactors between -40 to +200 °C
AviadoBio expands presence at Canary Wharf
The company has acquired 11,000 sqft of laboratory and office space in Canary Wharf to accommodate the growing team
Upcoming event
Making Pharmaceuticals
23–24 April 2024 | Exhibition | Coventry, UK
See all
Related Content
Recruitment
Abivax strengthens its management team
Regulatory
ABIVAX’s ABX464 reduces HIV reservoir in blood in second phase clinical trial
ABX464 is the first drug candidate to show statistically significant (p<0.01) reduction of the HIV viral reservoir
Research & Development
Evotec and ABIVAX collaborate to develop novel antiviral agents
Evotec and ABIVAX have announced a strategic collaboration to discover and develop novel treatments for multiple viral infectious diseases
Regulatory
First ever evidence of treatment-induced reduction in HIV reservoirs
Preliminary clinical trial results support ABX464's potential to become a key functional cure element for HIV
Manufacturing
Abivax enters into a manufacturing agreement with PCAS for ABX464
Collaboration ensures drug candidate supply for upcoming clinical trials
Research & Development
Abivax makes three new personnel changes
Including the appointment of a new Chief Medical Officer
Pharmaceutical
Abivax makes two appointments to executive management team
Karl Birthistle joins as VP of Global Regulatory Affairs, while Daniel Kenny becomes VP of Business Development
Subscribe now